Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression After First-Line Gemcitabine Plus Cisplatin
Cancer Research and Treatment - South Korea
doi 10.4143/crt.2018.326
Full Text
Open PDFAbstract
Available in full text
Date
July 15, 2019
Authors
Publisher
Korean Cancer Association